PDCD1 and melanoma: LAG-3, PD-1 and other inhibitory receptors are often co-expressed on tumor-infiltrating T cells in various types of cancers, such as squamous cell carcinoma, NSCLC, ovarian cancer, melanoma, colorectal adenocarcinoma, and fibrosarcoma (87–90).